col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer-Verlag: Infectious Diseases and Therapy
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―20 Effect of Tocilizumab Treatment on Patients with Coronavirus Disease 2019 and Bacteremia: A Retrospective Cohort Study Masaatsu Kuwahara, Misa Kamigaito, Shou Nitta, Kana Hasegawa, Hiromoto Murakami, Tomoyuki Kobayashi, et al. (+3)
2 [GO] 2021―Dec―29 Effect of Previous SARS-CoV-2 Infection on Antibody Response to a Single Immunization with the Pfizer BNT162b mRNA Vaccine Among Healthcare Workers in Foggia, Italy Tobias Homan, Francesca Fortunato, Gaetano Corso, Pier Luigi Lopalco, Rosa Prato, Domenico Martinelli
3 [GO] 2021―Dec―27 Brand-Specific Enhanced Safety Surveillance Study of GSK’s Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season Gaël Dos Santos, Hao Wang, Pooja Jindal, Maria Rybo, Hélène Roul, Sridevi Pallem, et al. (+8)
4 [GO] 2021―Dec―10 Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) Tommaso Manciulli, Michele Spinicci, Alessandro Bartoloni, Lorenzo Zammarchi
5 [GO] 2021―Dec―10 A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, Emanuela Barisione, Stefano Centanni, Nadia Castaldo, et al. (+22)
6 [GO] 2021―Dec―08 A Randomized, Double-Blind, Placebo-Controlled, First-in-Human Clinical Trial to Assess Safety, Tolerability, and Pharmacokinetics of LY-CovMab, a Potent Human Neutralizing Antibody Against SARS-CoV-2 Qian Zhang, Renpeng Zhou, Jingjing Yang, Changlin Dou, Tianyi Gan, Fujia Liu, et al. (+4)
7 [GO] 2021―Dec―03 Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine Sarinya Boongird, Piyatida Chuengsaman, Chavachol Setthaudom, Arkom Nongnuch, Montira Assanatham, Salinnart Phanprasert, et al. (+6)
8 [GO] 2021―Nov―24 Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection Eszter Fodor, Veronika Müller, Zsolt Iványi, Tímea Berki, Olga Kuten Pella, István Hornyák, et al. (+13)
9 [GO] 2021―Nov―22 Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19 Ritam Das, Komal Kotra, Pulkit Singh, Belinda Loh, Sebastian Leptihn, Urmi Bajpai
10 [GO] 2021―Nov―14 A Randomized Controlled Trial to Evaluate the Safety and Efficacy of a Novel Inhaled Biologic Therapeutic in Adults with Respiratory Distress Secondary to COVID-19 Infection Michael Roshon, Luciano Lemos-Filho, Holli Cherevka, Laura Goldberg, Kristin Salottolo, David Bar-Or
11 [GO] 2021―Nov―11 Lack of Prognostic Value of SARS-CoV2 RT-PCR Cycle Threshold in the Community Miguel J. Martínez, Luca Basile, Antoni Sisó-Almirall, Victor Cristino, Genoveva Cuesta, Juan Carlos Hurtado, et al. (+7)
12 [GO] 2021―Nov―10 Efficacy and Safety of Immunomodulators in Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Thundon Ngamprasertchai, Rattagan Kajeekul, Chaisith Sivakorn, Narisa Ruenroegnboon, Viravarn Luvira, Tanaya Siripoon, Nantasit Luangasanatip
13 [GO] 2021―Oct―28 Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data Natalia A. Díaz, Rosa de Miguel, Fernando Agüero, Omar Sued, José R. Arribas, Juan Ambrosioni, et al. (+40)
14 [GO] 2021―Oct―25 Epidemiology of Viruses Causing Pediatric Community Acquired Pneumonia in Shanghai During 2010-2020: What Happened Before and After the COVID-19 Outbreak? Fei Li, Yuhan Zhang, Peng Shi, Linfeng Cao, Liyun Su, Yulan Zhang, et al. (+4)
15 [GO] 2021―Oct―23 Long-Term Effects of COVID-19 on Health Care Workers 1-Year Post-Discharge in Wuhan Tingting Liao, Daquan Meng, Lijuan Xiong, Shuting Wu, Lian Yang, Sufei Wang, et al. (+8)
16 [GO] 2021―Sep―28 In Vitro Evaluation of the Virucidal Activity of Different Povidone-Iodine Formulations Against Murine and Human Coronaviruses Manjunath Shet, Rosa Hong, David Igo, Marc Cataldo, Sailaja Bhaskar
17 [GO] 2021―Sep―16 Antibiotic Prescriptions Targeting Bacterial Respiratory Infections in Admitted Patients with COVID-19: A Prospective Observational Study Johan Van Laethem, Stephanie Wuyts, Sven Van Laere, Silke Dirkx, Lucie Seyler, Rembert Mertens, et al. (+4)
18 [GO] 2021―Sep―02 Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, Emanuela Barisione, Stefano Centanni, Nadia Castaldo, et al. (+50)
19 [GO] 2021―Aug―30 Reversal of SARS-CoV2-Induced Hypoxia by Nebulized Sodium Ibuprofenate in a Compassionate Use Program Oscar Salva, Pablo A. Doreski, Celia S. Giler, Dario C. Quinodoz, Lucia G. Guzmán, Sonia E. Muñoz, et al. (+20)
20 [GO] 2021―Aug―27 Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial Masaharu Shinkai, Kenji Tsushima, Shingo Tanaka, Eri Hagiwara, Norihito Tarumoto, Ichiro Kawada, et al. (+33)
21 [GO] 2021―Aug―25 Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern Marco Falcone, Giusy Tiseo, Beatrice Valoriani, Chiara Barbieri, Sara Occhineri, Paola Mazzetti, et al. (+6)
22 [GO] 2021―Aug―25 Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals Soumya Jaganathan, Francis Stieber, Sonia N. Rao, Vladyslav Nikolayevskyy, Davide Manissero, Nadia Allen, et al. (+2)
23 [GO] 2021―Aug―13 Efficacy and Safety of Corticosteroid Use in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis Yuqing Cui, Yali Sun, Junyi Sun, Huoyan Liang, Xianfei Ding, Xueyi Sun, et al. (+2)
24 [GO] 2021―Aug―13 Lower Serum Angiotensin-Converting Enzyme Level in Relation to Hyperinflammation and Impaired Antiviral Immune Response Contributes to Progression of COVID-19 Infection Yuying Chen, Da Huang, Wei Yuan, Jiang Chang, Zhize Yuan, Di Wu, et al. (+4)
25 [GO] 2021―Aug―10 Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial Mohammad Bosaeed, Ebrahim Mahmoud, Ahmad Alharbi, Hadeel Altayib, Hawra Albayat, Faisal Alharbi, et al. (+24)
26 [GO] 2021―Aug―10 Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial Konstantinos Tsiakos, Antonios Tsakiris, Georgios Tsibris, Pantazis-Michael Voutsinas, Periklis Panagopoulos, Maria Kosmidou, et al. (+25)
27 [GO] 2021―Aug―10 Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure Yuichiro Shindo, Yasuhiro Kondoh, Akiko Kada, Yohei Doi, Keisuke Tomii, Hiroshi Mukae, et al. (+13)
28 [GO] 2021―Aug―10 A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2 Ramesh Nathan, Imad Shawa, Inmaculada De La Torre, Jennifer M. Pustizzi, Natalie Haustrup, Dipak R. Patel, Gregory Huhn
29 [GO] 2021―Aug―09 Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2 Elena Riester, Mario Majchrzak, Annelies Mühlbacher, Caroline Tinguely, Peter Findeisen, Johannes Kolja Hegel, et al. (+6)
30 [GO] 2021―Aug―09 Multicenter Evaluation of a Fully Automated High-Throughput SARS-CoV-2 Antigen Immunoassay Dominik Nörz, Flaminia Olearo, Stojan Perisic, Matthias F. Bauer, Elena Riester, Tanja Schneider, et al. (+3)
31 [GO] 2021―Jul―23 Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series Emanuela Messina, Anna Danise, Giulio Ferrari, Andrea Andolina, Matteo Chiurlo, Marie Razanakolona, et al. (+3)
32 [GO] 2021―Jul―22 Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations Fei Chen, Lanting Hao, Shiheng Zhu, Xinyuan Yang, Wenhao Shi, Kai Zheng, et al. (+2)
33 [GO] 2021―Jul―14 Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital Elisabeth Paramythiotou, George Dimopoulos, Nikolaos Koliakos, Maria Siopi, Sophia Vourli, Spyros Pournaras, Joseph Meletiadis
34 [GO] 2021―Jul―12 COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Deficiencies as Determinants of Risk and Severity of Disease: A Narrative Review Miklos P. Salgo
35 [GO] 2021―Jul―11 Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia Timothée Klopfenstein, Vincent Gendrin, Aurélie Gerazime, Thierry Conrozier, Jean-Charles Balblanc, Pierre-Yves Royer, et al. (+9)
36 [GO] 2021―Jul―10 Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection Marc Scherlinger, Renaud Felten, Floriane Gallais, Charlotte Nazon, Emmanuel Chatelus, Luc Pijnenburg, et al. (+14)
37 [GO] 2021―Jul―09 Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis Weijun Jiang, Weiwei Li, Qiuyue Wu, Ying Han, Jing Zhang, Tao Luo, et al. (+4)
38 [GO] 2021―Jun―21 Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 Elda Righi, Massimo Mirandola, Fulvia Mazzaferri, Elisa Razzaboni, Amina Zaffagnini, Anna Erbogasto, et al. (+12)
39 [GO] 2021―Jun―16 The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece Evangelos J. Giamarellos-Bourboulis, George L. Daikos, Panagiotis Gargalianos, Charalambos Gogos, Marios Lazanas, Periklis Panagopoulos, et al. (+3)
40 [GO] 2021―Jun―16 In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients Raquel Rubio-Acero, Noemi Castelletti, Volker Fingerle, Laura Olbrich, Abhishek Bakuli, Roman Wölfel, et al. (+130)
41 [GO] 2021―Jun―14 A Novel Prediction Model of COVID-19 Progression: A Retrospective Cohort Study Wei Xu, ChenLu Huang, Ling Fei, WeiXia Li, XuDong Xie, Qiang Li, Liang Chen
42 [GO] 2021―Jun―13 Reduction in Sporadic Norovirus Infections Following the Start of the COVID-19 Pandemic, 2019-2020, Philadelphia Irving Nachamkin, Melissa Richard-Greenblatt, Mei Yu, Hong Bui
43 [GO] 2021―Jun―11 Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19 Fernanda Meira, Estela Moreno-García, Laura Linares, Irene Macaya, Adria Tomé, Marta Hernández-Meneses, et al. (+17)
44 [GO] 2021―Jun―10 Dynamic Changes in the Immune Response Correlate with Disease Severity and Outcomes During Infection with SARS-CoV-2 Fang Zheng, Ruochan Chen, Run Yao, Yaxiong Huang, Xin Tan, Jiyang Liu, et al. (+2)
45 [GO] 2021―May―29 Dynamic Antibody Responses in Patients with Different Severity of COVID-19: A Retrospective Study Wanrong Lu, Ping Wu, Liang He, Yifan Meng, Peng Wu, Wencheng Ding, Jia Liu
46 [GO] 2021―May―11 Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia Matthew Geriak, Fadi Haddad, Ravina Kullar, Kristina L. Greenwood, MacKenzie Habib, Cole Habib, et al. (+2)
47 [GO] 2021―May―03 Prevalence and Mortality due to COVID-19 in HIV Co-Infected Population: A Systematic Review and Meta-Analysis Min Liang, Ning Luo, Mafeng Chen, Chunna Chen, Shivank Singh, Shantanu Singh, Shifan Tan
48 [GO] 2021―Apr―29 A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Belén Ruiz-Antorán, Aránzazu Sancho-López, Ferrán Torres, Ana Fernández-Cruz
49 [GO] 2021―Apr―29 Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study Rajesh Naidu Janapala, Jigar Patel, Omar Belfaqeeh, Abdulla Alhashmi, Ali Pourmand
50 [GO] 2021―Apr―07 Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019 Alanna C. McEneny-King, Jonathan P. R. Monteleone, Shamsah D. Kazani, Stephan R. Ortiz
51 [GO] 2021―Mar―31 A Novel Prediction Model for Long-Term SARS-CoV-2 RNA Shedding in Non-Severe Adult Hospitalized Patients with COVID-19: A Retrospective Cohort Study Chen Lu Huang, Ling Fei, WeiXia Li, Wei Xu, Xu Dong Xie, Qiang Li, Liang Chen
52 [GO] 2021―Mar―22 A Survey of Provider-Reported Use and Perceived Effectiveness of Medications for Symptom Management in Telemedicine and Outpatient Visits for Mild COVID-19 James B. O’Keefe, Lydia C. Newsom, Thomas H. Taylor
53 [GO] 2021―Mar―18 Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach Hsiao-Hsuan Jen, Wei-Jung Chang, Ting-Yu Lin, Chen-Yang Hsu, Amy Ming-Fang Yen, Chao-Chih Lai, Tony Hsiu-Hsi Chen
54 [GO] 2021―Mar―14 Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study Ricardo Salgado-Aranda, Nicasio Pérez-Castellano, Ivan Núñez-Gil, A. Josué Orozco, Norberto Torres-Esquivel, Jesús Flores-Soler, et al. (+9)
55 [GO] 2021―Feb―24 A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study Paul K. Drain, Madhavi Ampajwala, Christopher Chappel, Andre B. Gvozden, Melanie Hoppers, Melody Wang, et al. (+4)
56 [GO] 2021―Feb―02 Computational and Experimental Studies Reveal That Thymoquinone Blocks the Entry of Coronaviruses Into In Vitro Cells Huan Xu, Bing Liu, Zhen Xiao, Meiling Zhou, Lin Ge, Fan Jia, et al. (+8)
57 [GO] 2021―Jan―25 COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options Nicholas Rebold, Dana Holger, Sara Alosaimy, Taylor Morrisette, Michael Rybak
58 [GO] 2021―Jan―23 The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort Abdulkarim Abdulrahman, Islam AlSayed, Marwa AlMadhi, Jumana AlArayed, Sara Jaafar Mohammed, Aesha Khalid Sharif, et al. (+3)
59 [GO] 2021―Jan―22 Clinical Characteristics of Patients with Severe and Critical COVID-19 in Wuhan: A Single-Center, Retrospective Study Zhaohui Chen, Junyi Hu, Lilong Liu, Youpeng Zhang, Dandan Liu, Ming Xiong, et al. (+3)
60 [GO] 2021―Jan―12 Clinical Diagnostic Study of a Novel Injection Molded Swab for SARS-Cov-2 Testing Joshua K. Tay, Gail B. Cross, Louisa Sun, Alfred Chia, Jeremy Chee, Jerold Loh, et al. (+15)
61 [GO] 2021―Jan―09 Filling the Gap Until Full Vaccine Deployment in the War on Coronavirus Disease-19 Sabrina Mattoli
62 [GO] 2021―Jan―08 Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study Antonio Vena, Lucia Taramasso, Antonio Di Biagio, Malgorzata Mikulska, Chiara Dentone, Andrea De Maria, et al. (+18)
63 [GO] 2020―Dec―06 Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study Belén Ruiz-Antorán, Aránzazu Sancho-López, Ferrán Torres, Víctor Moreno-Torres, Itziar de Pablo-López, Paulina García-López, et al. (+18)
64 [GO] 2020―Nov―26 Correction to: Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains Eriko Padron-Regalado
65 [GO] 2020―Nov―09 Correction to: Early Treatment of COVID-19 Disease: A Missed Opportunity Jamie I. Forrest, Craig R. Rayner, Jay J. H. Park, Edward J. Mills
66 [GO] 2020―Nov―02 Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study Laila Carolina Abu Esba, Rahaf Ali Alqahtani, Abin Thomas, Nour Shamas, Lolowa Alswaidan, Gahdah Mardawi
67 [GO] 2020―Oct―28 Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients with COVID-19 and Diabetes Juan Huang, Lin Zhu, Xiangli Bai, Xiong Jia, Yajing Lu, Aiping Deng, et al. (+2)
68 [GO] 2020―Oct―16 Chest CT Features of 182 Patients with Mild Coronavirus Disease 2019 (COVID-19) Pneumonia: A Longitudinal, Retrospective and Descriptive Study Huaping Liu, Shiyong Luo, Youming Zhang, Yuzhu Jiang, Yuting Jiang, Yayi Wang, et al. (+6)
69 [GO] 2020―Oct―13 Early Treatment of COVID-19 Disease: A Missed Opportunity Jamie I. Forrest, Craig R. Rayner, Jay J. H. Park, Edward J. Mills
70 [GO] 2020―Sep―28 Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study Cheng Ding, Xuewen Feng, Yanfei Chen, Jing Yuan, Ping Yi, Yongtao Li, et al. (+6)
71 [GO] 2020―Sep―20 Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial Danyal Ibrahim, Latha Dulipsingh, Lisa Zapatka, Reginald Eadie, Rebecca Crowell, Kendra Williams, et al. (+4)
72 [GO] 2020―Sep―16 Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All Grant W. Waterer, Jordi Rello
73 [GO] 2020―Sep―04 Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals Georg M. N. Behrens, Anne Cossmann, Metodi V. Stankov, Bianca Schulte, Hendrik Streeck, Reinhold Förster, et al. (+16)
74 [GO] 2020―Sep―02 Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study Qiang Li, Weixia Li, Yinpeng Jin, Wei Xu, Chenlu Huang, Li Li, et al. (+3)
75 [GO] 2020―Aug―18 Correction to: A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19 Sonia N. Rao, Davide Manissero, Victoria R. Steele, Josep Pareja
76 [GO] 2020―Aug―12 Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19 Joseph Meletiadis, Sotirios Tsiodras, Panagiotis Tsirigotis
77 [GO] 2020―Aug―01 The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse Taylor Morrisette, Thomas P. Lodise, Marc H. Scheetz, Srijib Goswami, Jason M. Pogue, Michael J. Rybak
78 [GO] 2020―Jul―28 A Narrative Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19 Sonia N. Rao, Davide Manissero, Victoria R. Steele, Josep Pareja
79 [GO] 2020―Jul―10 That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19 Matthew R. Davis, Erin K. McCreary, Jason M. Pogue
80 [GO] 2020―Jul―08 Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease Danielle E. Anderson, Velraj Sivalingam, Adrian Eng Zheng Kang, Abhishek Ananthanarayanan, Harsha Arumugam, Timothy M. Jenkins, et al. (+2)
81 [GO] 2020―May―30 COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia Helvécio Cardoso Corrêa Póvoa, Gabriela Ceccon Chianca, Natalia Lopes Pontes Póvoa Iorio
82 [GO] 2020―May―27 Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review David C. Fajgenbaum, Johnson S. Khor, Alexander Gorzewski, Mark-Avery Tamakloe, Victoria Powers, Joseph J. Kakkis, et al. (+16)
83 [GO] 2020―Apr―23 Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains Eriko Padron-Regalado
84 [GO] 2020―Apr―08 Coronavirus: Update Related to the Current Outbreak of COVID-19 Giovanni Gabutti, Erica d’Anchera, Federica Sandri, Marta Savio, Armando Stefanati


[de][en]

Last change 2022―Jan―20 20:43:25 UTC

© Daten-Quadrat 2022       Done in 0.026 sec